teriflunomide

Known as: Teriflunomida, (Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide, Teriflunomidum 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND Teriflunomide is an oral disease-modifying therapy approved for treatment of relapsing or relapsing-remitting multiple… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND In previous studies, teriflunomide significantly reduced the annualised relapse rate (ARR) and disability progression… (More)
Is this relevant?
2014
2014
INTRODUCTION Teriflunomide, indicated for the treatment of relapsing-remitting multiple sclerosis, is contraindicated in… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Teriflunomide is a once-daily oral immunomodulator approved for the treatment of relapsing-remitting multiple… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Teriflunomide is a new oral disease-modifying therapy for relapsing forms of multiple sclerosis. METHODS We… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Review
2011
Review
2011
Significant progress in multiple sclerosis (MS) treatment has been made over the last two decades, including the emergence of… (More)
Is this relevant?
2010
2010
Teriflunomide (TFN) is an inhibitor of de novo pyrimidine synthesis and the active metabolite of leflunomide. Leflunomide is… (More)
Is this relevant?
2009
2009
Teriflunomide is an orally available anti-inflammatory drug that prevents T and B cell proliferation and function by inhibition… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Teriflunomide, a dihydro-orotate dehydrogenase inhibitor, has immunomodulatory effects, including the ability to… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2005
2005
OBJECTIVE Leflunomide, a potent disease-modifying antirheumatic drug of the isoxazole class, exhibits antiinflammatory… (More)
Is this relevant?